Back to results
US 11,684,592 B2Granted
Multiresistant-tumour sensitiser
AssigneeInstituto Nacional De Neurologia Y Neurocirugia Manuel Velasco Suarez
InventorIrma Gabriela Gonzalez Herrera
Life of this patent
Estimating the term…
Abstract
The present invention refers to the use of the compound Cur-[G-2]-OH as a sensitizing agent in a wide range of multidrug-resistant tumors, especially glioblastoma, which are characterized by overexpression of the Nrf2 pathway.
Claims4
A method for sensitizing multi-resistant tumors characterized by overexpression of the Nrf2 pathway in humans, the method comprising the steps of administering to a patient a medicament comprising a compound Cur-[G-2]-OH of formula:
- wherein the medicament is administered to the patient prior to the administration of an anticancer therapy.
Dependencies are inferred from the claim text.